Aptose Biosciences is a science-driven clinical-stage biotechnology company developing first-in-class targeted agents to address unmet clinical need in multiple hematologic malignancies. CG-806, our oral mutation-agnostic FLT3/BTK inhibitor, is being developed for the treatment of patients with certain B-cell malignancies, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and certain non-Hodgkin’s lymphomas (NHL) who are resistant or intolerant to conventional treatments. CG-806 is also being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML), including the emerging populations resistant to approved targeted therapies. APTO-253, our first-in-class MYC Inhibitor, is being developed for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
View Top Employees from Aptose Biosciences, Inc.Website | http://www.aptose.com |
Ticker | APTO |
Revenue | $283000 |
Employees | 49 (49 on RocketReach) |
Founded | 2014 |
Address | 12770 High Bluff Drive Suite 120, San Diego, California 92130, US |
Phone | (858) 926-2730 |
Fax | (905) 234-2120 |
Technologies |
JavaScript,
HTML,
PHP
+24 more
(view full list)
|
Industry | Business Services, Biotechnology, Biotechnology Research, Biopharma, Oncology, Organizations, Education, Drug Discovery, Myelodysplastic Syndromes, Health Care, Acute Myeloid Leukemia, Science and Engineering, Hematology, Clinical Trials, Drug Development & Discovery, Apoptosis |
Web Rank | 4 Million |
Keywords | Aptose Biosciences, Aptose Pharmaceutical, Aptose, Aptose Biosciences San Diego, "Arq 531" "Plasma Protein Binding" |
Competitors | Castle Biosciences, Inc., Metacrine, Inc., Optherion, Inc., Rosetta Genomics, Trovagene, Inc. |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5419 Companies, NAICS Code 54199 Companies |
Looking for a particular Aptose Biosciences, Inc. employee's phone or email?
The Aptose Biosciences, Inc. annual revenue was $283000 in 2024.
Rafael Bejar is the Chief Medical Officer, Senior Vice-President of Aptose Biosciences, Inc..
49 people are employed at Aptose Biosciences, Inc..
Aptose Biosciences, Inc. is based in San Diego, California.
The NAICS codes for Aptose Biosciences, Inc. are [54, 541, 5419, 54199].
The SIC codes for Aptose Biosciences, Inc. are [873, 87].